Stock-Based Compensation for Solventum (SOLV)
Stock-Based Compensation for Solventum (SOLV): headline value $83.00M · YoY +43.8%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
SOLV
Currently viewingStock-Based CompensationSwitch metric
Latest period
$83.00M
YoY change
+43.8%
5Y CAGR
+35.7%
Peak year (2025)
$161.00M
Latest annual
$161.00M
Stock-Based Compensation history chart for Solventum (SOLV) from 2020 to 2025
Stock-Based Compensation history table for Solventum (SOLV) from 2020 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $161.00M | +43.8% | ||
| 2024 | $112.00M | +187.2% | ||
| 2023 | $39.00M | +5.4% | ||
| 2022 | $37.00M | -2.6% | ||
| 2021 | $38.00M | +8.6% | ||
| 2020 | $35.00M | — |
Stock-Based Compensation values are taken from Solventum's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Solventum (SOLV) most recent annual stock-based compensation stands at $161.00M (2025) – surged 43.8% year-over-year.
Solventum stock-based compensation compound annual growth for the 2020–2025 (5 years) window is +35.7%, with the latest reading among the more recent periods of the dataset.
The dataset's maximum stock-based compensation sits at $161.00M (2025); the minimum reading of $35.00M dates to 2020.
Within Healthcare, Solventum (SOLV) ranks 5th among 8 peers we track. The peer median for stock-based compensation is $313.00M.
Solventum Stock-Based Compensation by Year
Solventum Stock-Based Compensation 2025: $161.00M
Solventum stock-based compensation in 2025 was $161.00M, surged 43.8% from 2024. This figure represents the highest annual value in the available history.
Solventum Stock-Based Compensation 2024: $112.00M
Solventum stock-based compensation in 2024 was $112.00M, surged 187.2% from 2023.
Solventum Stock-Based Compensation 2023: $39.00M
Solventum stock-based compensation in 2023 was $39.00M, grew 5.4% from 2022.
Solventum Stock-Based Compensation 2022: $37.00M
Solventum stock-based compensation in 2022 was $37.00M, edged down 2.6% below 2021.
Solventum Stock-Based Compensation 2021: $38.00M
Solventum stock-based compensation in 2021 was $38.00M.
See more financial history for Solventum (SOLV).
Sector peers — Stock-Based Compensation
Companies in the same sector as Solventum, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is Solventum's stock-based compensation?
Latest reported stock-based compensation for Solventum (SOLV) is $83.00M (period ending December 31, 2025).
How has Solventum stock-based compensation changed year-over-year?
Solventum (SOLV) stock-based compensation changed +43.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Solventum stock-based compensation?
Solventum (SOLV) stock-based compensation compound annual growth rate is +35.7% over the most recent 5 years available.
When did Solventum stock-based compensation hit its highest annual value?
Solventum stock-based compensation reached its highest annual value of $161.00M in 2025.
What was Solventum stock-based compensation in 2024?
Solventum (SOLV) stock-based compensation in 2024 was $112.00M.
What was Solventum stock-based compensation in 2025?
Solventum (SOLV) stock-based compensation in 2025 was $161.00M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
SOLV Overview
Company profile, financial tools, and key metrics
SOLV Revenue Counter
Earns $263.98 every second. See per minute, hour, and day.
SOLV Earnings Counter
Earns $49.34 per second net profit. See per minute, hour, and day.
SOLV Economic Scale
Exceeds Montenegro's GDP. Compare with world economies.
SOLV What If Invested
What if you had invested $1,000? See historical returns from any date.
SOLV How It Makes Money
Discover visual breakdown of $8.32B in revenue — where it comes from and where it goes.
SOLV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
SOLV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
SOLV Daily Price Character
Steady · 48.6% historical win rate (green days). Streaks & record days.
SOLV Buybacks
See repurchase history & metrics. Shareholder yield & SBC comparison.